Literature DB >> 29145752

Association of Hormonal Contraception With Suicide Attempts and Suicides.

Charlotte Wessel Skovlund1, Lina Steinrud Mørch1, Lars Vedel Kessing1, Theis Lange1, Øjvind Lidegaard1.   

Abstract

OBJECTIVE: The purpose of this study was to assess the relative risk of suicide attempt and suicide in users of hormonal contraception.
METHOD: The authors assessed associations between hormonal contraceptive use and suicide attempt and suicide in a nationwide prospective cohort study of all women in Denmark who had no psychiatric diagnoses, antidepressant use, or hormonal contraceptive use before age 15 and who turned 15 during the study period, which extended from 1996 through 2013. Nationwide registers provided individually updated information about use of hormonal contraception, suicide attempt, suicide, and potential confounding variables. Psychiatric diagnoses or antidepressant use during the study period were considered potential mediators between hormonal contraceptive use and risk of suicide attempt. Adjusted hazard ratios for suicide attempt and suicide were estimated for users of hormonal contraception as compared with those who never used hormonal contraception.
RESULTS: Among nearly half a million women followed on average for 8.3 years (3.9 million person-years) with a mean age of 21 years, 6,999 first suicide attempts and 71 suicides were identified. Compared with women who never used hormonal contraceptives, the relative risk among current and recent users was 1.97 (95% CI=1.85-2.10) for suicide attempt and 3.08 (95% CI=1.34-7.08) for suicide. Risk estimates for suicide attempt were 1.91 (95% CI=1.79-2.03) for oral combined products, 2.29 (95% CI=1.77-2.95) for oral progestin-only products, 2.58 (95% CI=2.06-3.22) for vaginal ring, and 3.28 (95% CI=2.08-5.16) for patch. The association between hormonal contraceptive use and a first suicide attempt peaked after 2 months of use.
CONCLUSIONS: Use of hormonal contraception was positively associated with subsequent suicide attempt and suicide. Adolescent women experienced the highest relative risk.

Entities:  

Keywords:  Adolescents; Combined Oral Contraceptive Pill; Depression; Hormonal Contraception; Suicide; Suicide Attempt

Mesh:

Substances:

Year:  2017        PMID: 29145752     DOI: 10.1176/appi.ajp.2017.17060616

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  26 in total

Review 1.  A Systematic Review and Meta-analysis of the Adverse Effects of Levonorgestrel Emergency Oral Contraceptive.

Authors:  Nattawut Leelakanok; Janthima Methaneethorn
Journal:  Clin Drug Investig       Date:  2020-05       Impact factor: 2.859

Review 2.  Hormonal Contraceptives and Mood: Review of the Literature and Implications for Future Research.

Authors:  Thalia Robakis; Katherine E Williams; Lexi Nutkiewicz; Natalie L Rasgon
Journal:  Curr Psychiatry Rep       Date:  2019-06-06       Impact factor: 5.285

3.  Postpartum hormonal contraception use and incidence of postpartum depression: a systematic review.

Authors:  Angeline Ti; Kathryn M Curtis
Journal:  Eur J Contracept Reprod Health Care       Date:  2019-03-28       Impact factor: 1.848

Review 4.  Hormonal Treatments for Major Depressive Disorder: State of the Art.

Authors:  Jennifer B Dwyer; Awais Aftab; Rajiv Radhakrishnan; Alik Widge; Carolyn I Rodriguez; Linda L Carpenter; Charles B Nemeroff; William M McDonald; Ned H Kalin
Journal:  Am J Psychiatry       Date:  2020-05-27       Impact factor: 18.112

Review 5.  Hormonal Contraception and Depression: Updated Evidence and Implications in Clinical Practice.

Authors:  Franca Fruzzetti; Tiziana Fidecicchi
Journal:  Clin Drug Investig       Date:  2020-12       Impact factor: 2.859

6.  Understanding When and Why Some Adolescent Girls Attempt Suicide: An Emerging Framework Integrating Menstrual Cycle Fluctuations in Risk.

Authors:  Sarah A Owens; Tory A Eisenlohr-Moul; Mitchell J Prinstein
Journal:  Child Dev Perspect       Date:  2020-05-07

7.  Hormonal contraception and suicide: a new dimension of risk.

Authors:  Lloyd D Hughes; Olwkayode Majekodunmi
Journal:  Br J Gen Pract       Date:  2018-11       Impact factor: 5.386

8.  Hormonally Active Contraceptives Part I: Risks Acknowledged and Unacknowledged.

Authors:  William V Williams; Joel Brind; Laura Haynes; Michael D Manhart; Hanna Klaus; Angela Lanfranchi; Gerard Migeon; Mike Gaskins; Elvis I Seman; Lester Ruppersberger; Kathleen M Raviele
Journal:  Linacre Q       Date:  2021-01-27

9.  Clinical indications of premenstrual disorders and subsequent risk of injury: a population-based cohort study in Sweden.

Authors:  Unnur A Valdimarsdóttir; Donghao Lu; Qian Yang; Arvid Sjölander; Yuchen Li; Alexander Viktorin; Elizabeth R Bertone-Johnson; Weimin Ye; Fang Fang
Journal:  BMC Med       Date:  2021-05-26       Impact factor: 8.775

10.  [Physician's obligations to inform about complications based on a recent warning from drug authorities].

Authors:  G Duttge; T Meyer
Journal:  Med Klin Intensivmed Notfmed       Date:  2020-02-07       Impact factor: 0.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.